Estimation of a Parameter and Its Exact Confidence Interval Following Sequential Sample Size Reestimation Trials
For confirmatory trials of regulatory decision making, it is important that adaptive designs under consideration provide inference with the correct nominal level, as well as unbiased estimates, and confidence intervals for the treatment comparisons in the actual trials. However, naive point estimate and its confidence interval are often biased in adaptive sequential designs. We develop a new procedure for estimation following a test from a sample size reestimation design. The method for obtaining an exact confidence interval and point estimate is based on a general distribution property of a pivot function of the Self-designing group sequential clinical trial by Shen and Fisher (1999, Biometrics55, 190–197). A modified estimate is proposed to explicitly account for futility stopping boundary with reduced bias when block sizes are small. The proposed estimates are shown to be consistent. The computation of the estimates is straightforward. We also provide a modified weight function to improve the power of the test. Extensive simulation studies show that the exact confidence intervals have accurate nominal probability of coverage, and the proposed point estimates are nearly unbiased with practical sample sizes.
Document Type: Research Article
Affiliations: 1: Department of Mathematical Sciences, Indiana University at South Bend, South Bend, Indiana 46634, U.S.A. 2: Department of Biostatistics, M. D. Anderson Cancer Center, Houston, Texas 77030, U.S.A., Email: email@example.com
Publication date: 2004-12-01